Neuralink, Elon Musk's brain-computer interface company, is launching a clinical trial in the UAE — and the announcement came just one day before President Donald Trump arrived in the country.
The company said on Wednesday that it's partnering with the Cleveland Clinic for a clinical trial in Abu Dhabi, its first outside of the US. Called UAE-Prime, the clinical trial will focus on how individuals with motor and speech impairment "can use thought to control devices & communicate," according to a post on X.
Just one day prior, Musk announced that Starlink, his satellite internet company that's a part of SpaceX, had been approved for maritime and aviation use in Saudi Arabia.
Both of the companies' Middle East expansions coincided with Trump's multi-day tour to the Gulf. A number of key business and tech leaders traveled to the region as well. Trump has largely focused on deal-making throughout the trip, previously saying he wants to secure $1 trillion worth of investments.
Representatives for Neuralink and Musk did not immediately respond to Business Insider's request for comment.
